ga68-dolacga
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 12, 2019 (NCT03908957)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 68-gallium
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06182865 | N/A | Dec 20, 2023 | Chang Gung University, Government of Taiwan |
| NCT05007548 | Phase 2 | Aug 31, 2021 | Chang Gung University, Government of Taiwan |
| NCT03908957 | Phase 1 | Feb 12, 2019 | Government of Taiwan, National Taiwan University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Taiwan | Government | 3 | 3 | 3 | 2019 |
| Chang Gung University | Academic/Hospital | 2 | 0 | 2 | 2021 |
| National Taiwan University | Academic/Hospital | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1